Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

April 10, 2018; 90 (15 Supplement) April 25, 2018

Behavioral correlates of cerebrospinal fluid concentrations of aminoacids and monoamine metabolites according to APOE-ɛ4 carrier status in dementia with Lewy bodies compared with Alzheimer’s dementia and cognitively healthy people (P4.190)

Fabricio De Oliveira, Marjorie Miraldo, Eduardo Castro-Neto, Fernando Machado, Sandro Almeida, Sandro Matas, Paulo Bertolucci, Maria Naffah-Mazzacoratti
First published April 9, 2018,
Fabricio De Oliveira
1Department of Neurology and Neurosurgery, Federal University of Sao Paulo - UNIFESP Sao Paulo Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marjorie Miraldo
1Department of Neurology and Neurosurgery, Federal University of Sao Paulo - UNIFESP Sao Paulo Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduardo Castro-Neto
1Department of Neurology and Neurosurgery, Federal University of Sao Paulo - UNIFESP Sao Paulo Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Machado
1Department of Neurology and Neurosurgery, Federal University of Sao Paulo - UNIFESP Sao Paulo Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandro Almeida
2Department of Biophysics, Federal University of Sao Paulo - UNIFESP Sao Paulo Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandro Matas
1Department of Neurology and Neurosurgery, Federal University of Sao Paulo - UNIFESP Sao Paulo Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paulo Bertolucci
1Department of Neurology and Neurosurgery, Federal University of Sao Paulo - UNIFESP Sao Paulo Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Naffah-Mazzacoratti
3Department of Biochemistry, Federal University of Sao Paulo - UNIFESP Sao Paulo Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Behavioral correlates of cerebrospinal fluid concentrations of aminoacids and monoamine metabolites according to APOE-ɛ4 carrier status in dementia with Lewy bodies compared with Alzheimer’s dementia and cognitively healthy people (P4.190)
Fabricio De Oliveira, Marjorie Miraldo, Eduardo Castro-Neto, Fernando Machado, Sandro Almeida, Sandro Matas, Paulo Bertolucci, Maria Naffah-Mazzacoratti
Neurology Apr 2018, 90 (15 Supplement) P4.190;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: To study associations of cerebrospinal fluid aminoacids and monoamine metabolites with behavior in dementia with Lewy bodies (DLB) compared with Alzheimer’s dementia (AD) and cognitively healthy people.

Background: Brain monoamine activity and aminoacid concentrations may correlate with behavioral features, reflecting their metabolism in dementia.

Design/Methods: Consecutive outpatients with probable DLB (fourth consensus report of the DLB Consortium) were paired with outpatients with late-onset AD (NIA-AA criteria) by gender, Clinical Dementia Rating (CDR) and Mini-Mental State Examination scores, and with cognitively healthy controls by gender and age (±1 year). Genotyping for rs7412/rs429358 was undertaken with TaqMan® Real-Time PCR technology. Cerebrospinal fluid concentrations of aminoacids (aspartate, glycine, glutamine, glutamate, taurine, GABA) and monoamine metabolites (HVA, 5-HIAA, VMA, MHPG, L-DOPA) were assessed by reverse-phase high-performance liquid chromatography, and correlated with Neuropsychiatric Inventory (NPI) domains.

Results: Twenty DLB participants (77.00±9.0 years-old, CDR sum-of-boxes 10.15±3.7, NPI 48.25±22.4, nine APOE-ɛ4 carriers) were paired with twenty AD participants (80.35±5.9 years-old, CDR sum-of-boxes 9.43±3.5, NPI 24.45±11.8, nine APOE-ɛ4 carriers) and twenty controls (77.15±9.0 years-old, CDR sum-of-boxes 0.25±0.5, NPI 11.00±10.1, three APOE-ɛ4 carriers). Aminoacids and the HVA/5-HIAA ratio were associated with apathy, dysphoria, or both in AD and DLB. Associations for APOE-ɛ4 carriers: lower levels of HVA, 5-HIAA, glutamate and taurine in DLB (p<0.05); glutamine with night-time disturbances (p<0.001); aspartate, glycine and the HVA/5-HIAA ratio with hallucinations in DLB (p<0.03); GABA, aspartate, glycine, glutamine and taurine with anxiety in AD (p<0.04). Associations for APOE-ɛ4 non-carriers: higher levels of glutamate in AD than in DLB (p=0.002); GABA and taurine with hallucinations and agitation in DLB (p<0.01); GABA, aspartate, glycine and glutamate with anxiety in DLB (p<0.0001); aspartate and glycine with night-time disturbances in DLB (p<0.001); VMA with dysphoria, delusions and night-time disturbances in AD (p<0.03). Levels of monoamine metabolites were unaffected by pharmacotherapy.

Conclusions: Neurotransmitter dysfunction may differentially affect behavioral phenotypes in dementia syndromes.

Study Supported by:

FAPESP (grant #2015/10109-5)

Disclosure: Dr De Oliveira has nothing to disclose. Dr. Miraldo has nothing to disclose. Dr. Castro has nothing to disclose. Dr. Machado has nothing to disclose. Dr. Almeida has nothing to disclose. Dr. Matas has nothing to disclose. Dr. Bertolucci has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Janssen, Merck, Novartis, Roche, Servier. Dr. Naffah-Mazzacoratti has nothing to disclose.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise